Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > funny biotech1973 , you sure sound like one of the
View:
Post by GoBBs on Apr 07, 2020 8:27am

funny biotech1973 , you sure sound like one of the

Newcamo Pando group !!

biostock1973 , Member Since: June 28, 2018
Comment by biotech1973 on Apr 07, 2020 10:17am
MORE OVER I KNOW U SINCE PUMPING DAYS. Gobb was the biggest of all the pumpers, but since he lost money, he wants noone to invest. Thats the only reason company is BAD. Lol
Comment by GoBBs on Apr 07, 2020 11:00am
Let their actions speak the truth biotech1973 ... Did they ( PLI/Thomvest ) wipe out ALL previous shareholders ? YES Have they re-submitted the BLA ? NO , 2 years so far to complete CMC changes. Did Thomvest get 100m of unearned interest ? YES  Did Thomvest do a hostile takeover from the shareholders ? YES. Has Ryplazim been apporoved ? NO Is there going to be a lawsuit ? YES Will they re ...more  
Comment by biotech1973 on Apr 07, 2020 12:52pm
Did they ( PLI/Thomvest ) wipe out ALL previous shareholders ? YES Have they re-submitted the BLA ? NO , 2 years so far to complete CMC changes. Did Thomvest get 100m of unearned interest ? YES Did Thomvest do a hostile takeover from the shareholders ? YES.( But they informed before) Has Ryplazim been apporoved ? NO ( Stupif question, thats the reason , we are at 200 million valuation) Is there ...more  
Comment by GoBBs on Apr 07, 2020 1:31pm
fair enough .. everyone  has their own perspective. I never said don't buy it either if you think the risk reward is there like it used to be ... but one last thing, whats stopping them them from "saving themselves" all over again and wiping the remaining shareholders out all over again ?  Anyway peace.
Comment by biotech1973 on Apr 07, 2020 2:24pm
Debts. Before they had huge amount of debts because of which noone was lending them a penny which they desperatly needed. Now they have cash in hand, no financial liabilities and super low float. They can easily ask for money in extreme cases. Before float was over 1 billion and now 30 Million.
Comment by GoBBs on Apr 07, 2020 2:32pm
ya and they could of done a rights offering before wiping everyone out instead of after and spinning it as you should be happy to be part of the future company. But that would be a responsible company that includes their shareholders not throws them over board. I hope Ryplazim gets approved and I hope we successfully sue the sh yt out of these people.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities